Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Level Bio ABNGM:LEVBIO +31.94%22 PB Ratio is 54.29 as of Jul. 17, 2026, which is 507% above its 10-year median of 8.94. GuruFocus rates NGM:LEVBIO with a GF Score™ of 22/100. The stock has 4 warning signs investors should review. Among 195 Medical Diagnostics & Research companies, Level Bio AB ranks worse than 98.97% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-17), Level Bio AB's share price is kr0.38. Level Bio AB's Book Value per Share for the quarter that ended in Mar. 2026 was kr0.01. Hence, Level Bio AB's PB Ratio of today is 54.29.
The historical rank and industry rank for Level Bio AB's PB Ratio or its related term are showing as below:
NGM:LEVBIO'
s PB Ratio Range Over the Past 10 Years
Min: 2.47 Med: 8.94 Max: 54.28
Current: 54.28
During the past 13 years, Level Bio AB's highest PB Ratio was 54.28. The lowest was 2.47. And the median was 8.94.
NGM:LEVBIO's PB Ratio is ranked worse than 98.97% of 195
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.01
vs NGM:LEVBIO: 54.28
During the past 12 months, Level Bio AB's average Book Value Per Share Growth Rate was -85.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -69.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -35.10% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -3.00% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Level Bio AB was 123.80% per year. The lowest was -71.70% per year. And the median was -11.35% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Level Bio AB PB Ratio Related Terms
Level Bio AB PB Ratio Historical Data
* Premium members only.
The historical data trend for Level Bio AB's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Level Bio AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Level Bio AB PB Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Level Bio AB's PB Ratio distribution charts can be found below:
* The bar in red indicates where Level Bio AB's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Level Bio AB's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Level Bio AB (NGM:LEVBIO) has a PB Ratio of 54.29 as of Jul. 17, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Level Bio AB and its competitors. This is 507% above median its historical median of 8.94. Over the past decade, Level Bio AB's PB Ratio has ranged from 2.47 to 54.28. According to the industry distribution chart, Level Bio AB ranks #193 out of 195 companies in the Medical Diagnostics & Research industry, placing it in the top 99%.
Is Level Bio AB's PB Ratio too high?
Level Bio AB's current PB Ratio of 54.29 is 507% above median its 10-year median of 8.94. Over the past 10 years, this metric has ranged from a low of 2.47 to a high of 54.28. The Medical Diagnostics & Research industry median PB Ratio is 2.01. Level Bio AB's value of 54.29 is 2601% above this industry median. Based on the distribution chart, Level Bio AB ranks #193 out of 195 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Level Bio AB has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Level Bio AB's PB Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Level Bio AB ranks #193 out of 195 companies for PB Ratio. This places Level Bio AB in the lower half of its industry. The industry median PB Ratio is 2.01. Level Bio AB's value of 54.29 is 2601% above this benchmark. Historically, Level Bio AB's own PB Ratio has ranged from 2.47 to 54.28 over the past decade. While the company's 10-year median is 8.94 vs. the industry median of 2.01, Level Bio AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Diagnostics & Research company?
The median PB Ratio among Medical Diagnostics & Research companies is 2.01, based on 195 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Level Bio AB's current PB Ratio of 54.29 is 2601% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Level Bio AB and its competitors. For the Medical Diagnostics & Research industry, the median PB Ratio is 2.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Level Bio AB's current PB Ratio is 54.29, which is 507% above median its own 10-year median of 8.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Level Bio AB stock overvalued right now?
Level Bio AB (NGM:LEVBIO) has a current PB Ratio of 54.29. The current PB Ratio is 54.29, which is 507% above median its 10-year median of 8.94 and 2601% above the Medical Diagnostics & Research industry median of 2.01. Level Bio AB's overall GF Score™ is 22/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Level Bio AB (NGM:LEVBIO), the current PB Ratio is 54.29 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Level Bio AB is a parent company and operates through subsidiary. It develops and manufactures diagnostic kits for the clinical market and also is a distributor and full service partner to molecular biology labs in the Nordics.
22GF Score
Get the complete analysis for NGM:LEVBIO
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGM:LEVBIO has been successfully added to your 
